Drug ID:Drug15
Drug Name:Clotrimazole
CID:2812
DrugBank ID:DB00257
Modality:Small Molecule
Groups:approved
US Approved:YES
Other Approved:YES
Identifier: NCT00061282
Molecular Formula:C22H17ClN2
Molecular Weight:344.8 g/mol
Isomeric SMILES:C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
Synonyms:clotrimazole; 23593-75-1; Clotrimazol; Mycosporin; Empecid; Mykosporin; Gyne lotrimin; Chlotrimazole; Trimysten; Gyne-Lotrimin
Phase 0: 0
Phase 1: 8
Phase 2: 14
Phase 3: 22
Phase 4: 12
Description:An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal cell membranes. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. [PubChem]

Molecular Structure

2D Molecular Structure

Knowledge Graph

dtIDCIDCompound NameGene IDGene NameSpeciesPubMed IDsAction
dt129 2812 Clotrimazole 5243 ABCB1 Cyprinus carpio (common carp) 22559005 Clotrimazole results in decreased expression of ABCB1 mRNA
dt130 2812 Clotrimazole 5243 ABCB1 Homo sapiens (human) 8917702 Clotrimazole inhibits the reaction [ABCB1 protein results in increased export of doxorubicin]|clotrimazole binds to ABCB1 protein
dt131 2812 Clotrimazole 5243 ABCB1 Homo sapiens (human) 12235267 Clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of vinblastine]|clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]
dt132 2812 Clotrimazole 5243 ABCB1 Homo sapiens (human) 8632764 Clotrimazole results in increased expression of ABCB1 protein
dt133 2812 Clotrimazole 8647 ABCB11 Homo sapiens (human) 24014644 Clotrimazole inhibits the reaction [ABCB11 protein results in increased transport of taurocholic acid]|clotrimazole results in decreased activity of ABCB11 protein
dt134 2812 Clotrimazole 18671 Abcb1a Mus musculus (house mouse) 12235267 Clotrimazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]
dt135 2812 Clotrimazole 1244 ABCC2 Homo sapiens (human) 11836020 Clotrimazole results in increased expression of ABCC2 protein|clotrimazole results in increased expression of ABCC2 mRNA
dt136 2812 Clotrimazole 8714 ABCC3 Homo sapiens (human) 27507784 Clotrimazole results in increased expression of ABCC3 mrna|sb 203580 inhibits the reaction [clotrimazole results in increased expression of ABCC3 mrna]|mapk14 promotes the reaction [clotrimazole results in increased expression of ABCC3 mrna]
dt137 2812 Clotrimazole 53 ACP2 Rattus norvegicus (Norway rat) 30047161 Clotrimazole results in increased expression of ACP2 mRNA
dt138 2812 Clotrimazole 53616 ADAM22 Rattus norvegicus (Norway rat) 30047161 Clotrimazole results in decreased expression of ADAM22 mRNA

  • No data available

Phase Distribution
Phase Description
  • Phase 0: Exploratory trials to assess drug behavior in humans
  • Phase 1: Safety trials to determine safe dosage range
  • Phase 2: Efficacy trials to evaluate therapeutic effects
  • Phase 3: Large-scale trials to confirm efficacy and safety
  • Phase 4: Post-marketing surveillance for long-term safety and efficacy

Trial IDTitlePhaseStatusSponsorIndicationsInterventions
NCT00061282 Clotrimazole Enemas for Pouchitis in Children and Adults PHASE1|PHASE2 TERMINATED Web Ulcerative Colitis|Pouchitis|Ileitis|Inflammatory… DRUG: Clotrimazole Details

Disease IDDisease NameDefinitionCategoryRelated DrugsMechanism
No data available

Strategy IDTherapeutic StrategySynonymsRelated DrugsMechanism
No data available

No related literature

You can run management commands to establish drug-literature associations